Form 4 for DGX Quest Diagnostics
Accepted 2022-05-20 00:00:00 ET · period of report 2022-04-18 · accession 0001022079-22-000091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-20 | 2022-05-18 | DGX | Gregg Vicky B | Dir | A - Grant | $0.00 | +1,292 | 16.9K | +8% | $0 | |
| 2022-05-20 | 2022-04-18 | DGX | Gregg Vicky B | Dir | L - Small Acq | $134.88 | +61 | 15.6K | +0.4% | +$8,228 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-18 | A | A | 1,292 | $0.00 | 16,922 | D | — | — | (F3) Represents an award of restricted share units. |
| 2 | Common | Common Stock | 2022-04-18 | L | A | 61 | $134.88 | 15,630 | D | — | — | (F1) Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transactions early on this Form 4. (F2) The amount includes approximately 169 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrored a dividend reinvestment plan that was sponsored by the registrant through February 2022. |